No dispatches yet.

Stryker Corporation

Mako orthopedic surgical robot, joint replacement

US$117B market cap~51,000 staffest. 1941stryker.com (opens stryker.com)Checked 10 Oct

The brief

Analyst view
  • Mako has performed over 1 million joint replacement procedures since 2006 and is the market leader.
  • Mako 4 consolidates hip, knee, spine and shoulder on one platform with Q Guidance.
  • Spine and Shoulder launched late 2024; expanding to full U.S. availability through 2025.

Technical approach

As reported
Platform Integration

Unified Mako system

Mako 4 consolidates hip, knee, spine and shoulder procedures on one platform with unified software and training.

Guidance System

Q Guidance AI system

Q Guidance uses real-time imaging and AI to guide the surgeon, adjust for patient movement, and detect critical anatomy.

New Capability

Hip revision for complex cases

Mako 4's first robotic hip revision navigates around existing implants and damaged bone automatically.

Soft Tissue

Spine and shoulder applications

Expansion from hard bone (hip/knee) to spine and shoulder, where the robot assists in less-structured anatomy and requires more real-time decision-making.

Primer